iTeos Therapeutics (ITOS) Short Interest Ratio & Short Volume → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free ITOS Stock Alerts $17.08 -0.60 (-3.39%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends iTeos Therapeutics Short Interest DataCurrent Short Interest2,160,000 sharesPrevious Short Interest2,070,000 sharesChange Vs. Previous Month+4.35%Dollar Volume Sold Short$38.79 millionShort Interest Ratio5.2 Days to CoverLast Record DateMay 15, 2024Outstanding Shares36,120,000 sharesFloat Size27,620,000 sharesShort Percent of Float7.82%Today's Trading Volume525,151 sharesAverage Trading Volume351,603 sharesToday's Volume Vs. Average149% Short Selling iTeos Therapeutics ? Sign up to receive the latest short interest report for iTeos Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartITOS Short Interest Over TimeITOS Days to Cover Over TimeITOS Percentage of Float Shorted Over Time Ad American AlternativeYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW iTeos Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20242,160,000 shares $38.79 million +4.4%7.8%5.2 $17.96 4/30/20242,070,000 shares $22.23 million -2.4%7.2%7.2 $10.74 4/15/20242,120,000 shares $24.93 million +3.4%7.4%7.7 $11.76 3/31/20242,050,000 shares $27.96 million +2.0%7.2%7.2 $13.64 3/15/20242,010,000 shares $21.73 million +11.7%7.1%7.8 $10.81 2/29/20241,800,000 shares $19.28 million +5.9%6.3%6 $10.71 Get the Latest News and Ratings for ITOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iTeos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,700,000 shares $17.12 million -1.7%6.0%5.5 $10.07 1/31/20241,730,000 shares $17.21 million +16.1%6.1%5.7 $9.95 1/15/20241,490,000 shares $16.88 million -6.9%5.2%4.5 $11.33 12/31/20231,600,000 shares $17.52 million -21.2%5.6%3.4 $10.95 12/15/20232,030,000 shares $22.03 million +17.3%7.1%4.3 $10.85 11/30/20231,730,000 shares $16.19 million +8.8%6.1%4 $9.36 11/15/20231,590,000 shares $16.01 million -9.1%5.6%3.7 $10.07 10/31/20231,750,000 shares $17.61 million -24.6%6.0%3.1 $10.06 10/15/20232,320,000 shares $20.97 million +28.2%7.9%4.3 $9.04 9/30/20231,810,000 shares $19.82 million +7.7%6.2%4.7 $10.95 9/15/20231,680,000 shares $20.70 million +3.7%5.7%4.4 $12.32 8/31/20231,620,000 shares $19.55 million +5.9%5.5%3.8 $12.07 8/15/20231,530,000 shares $18.21 million +8.5%5.3%3.5 $11.90 7/31/20231,410,000 shares $19.82 million -0.7%4.9%5.1 $14.06 7/15/20231,420,000 shares $19.51 million -6.0%4.9%5 $13.74 6/30/20231,510,000 shares $19.99 million -14.2%5.2%5.1 $13.24 6/15/20231,760,000 shares $24.99 million -7.4%6.1%6.1 $14.20 5/31/20231,900,000 shares $30.93 million +6.7%6.6%7.1 $16.28 5/15/20231,780,000 shares $26.52 million +6.6%6.1%7.3 $14.90 4/30/20231,670,000 shares $22.95 million -2.9%5.8%6.9 $13.74 4/15/20231,720,000 shares $23.50 million +1.8%5.9%6.8 $13.66 3/31/20231,690,000 shares $23.00 million +11.2%5.8%6.1 $13.61 3/15/20231,520,000 shares $23.91 million +2.0%5.3%5.2 $15.73 2/28/20231,490,000 shares $26.39 million +0.7%5.2%4.7 $17.71 2/15/20231,480,000 shares $27.44 million +0.7%5.1%4.6 $18.54 1/31/20231,470,000 shares $30.72 million +0.7%5.1%4.4 $20.90 1/15/20231,460,000 shares $27.84 million +5.0%5.1%4.4 $19.07 12/30/20221,390,000 shares $27.15 million -22.8%4.8%4.3 $19.53 12/15/20221,800,000 shares $38.65 million +9.8%6.2%5.9 $21.47 11/30/20221,640,000 shares $33.05 million -12.3%5.7%5.4 $20.15 11/15/20221,870,000 shares $38.67 million -7.4%6.5%6.1 $20.68 10/31/20222,020,000 shares $39.35 million +3.1%7.0%6.3 $19.48 10/15/20221,960,000 shares $35.32 million -27.4%6.8%5.9 $18.02 9/30/20222,700,000 shares $51.44 million +0.4%9.4%7.5 $19.054 Cryptos BETTER than Bitcoin (Ad)Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 9/15/20222,690,000 shares $54.61 million -0.4%9.3%7.1 $20.30 8/31/20222,700,000 shares $59.89 million -5.6%9.4%6.8 $22.18 8/15/20222,860,000 shares $72.64 million -1.7%9.9%6.8 $25.40 7/31/20222,910,000 shares $71.18 million +0.3%10.1%6.1 $24.46 7/15/20222,900,000 shares $71.05 million +4.3%10.1%5.8 $24.50 6/30/20222,780,000 shares $57.27 million +28.7%9.6%5.8 $20.60 6/15/20222,160,000 shares $39.68 million +9.6%7.5%4.4 $18.37 5/31/20221,970,000 shares $34.48 million +13.2%6.8%4.2 $17.50 5/15/20221,740,000 shares $32.33 million -17.9%6.0%4 $18.58 4/30/20222,120,000 shares $56.58 million +35.0%8.1%5.5 $26.69 4/15/20221,570,000 shares $51.28 million +9.8%6.0%4.1 $32.66 3/31/20221,430,000 shares $46.02 million +61.3%N/A0 $32.18 3/15/2022886,300 shares $31.84 million +0.0%3.5%1.7 $35.93 2/28/2022886,000 shares $32.01 million -4.0%3.5%1.8 $36.13 2/15/2022922,400 shares $33.27 million -30.1%3.9%1.8 $36.07 1/31/20221,320,000 shares $48.34 million -11.4%5.8%2.6 $36.62 1/15/20221,490,000 shares $59.09 million +108.5%N/A3.1 $39.66 12/31/2021714,800 shares $33.28 million +12.8%2.6%1.6 $46.56 12/15/2021633,700 shares $23.64 million +37.8%2.4%2.6 $37.31 11/30/2021460,000 shares $16.24 million -27.8%1.7%2.3 $35.30 11/15/2021636,900 shares $19.36 million -21.3%2.4%3.5 $30.40 10/29/2021809,500 shares $21.65 million +3.3%2.8%5.1 $26.75 10/15/2021784,000 shares $21.92 million -0.7%2.8%4.7 $27.96 9/30/2021789,300 shares $21.31 million +12.0%2.8%4.3 $27.00 9/15/2021704,600 shares $19.79 million -9.6%2.3%2.6 $28.09 8/31/2021779,500 shares $22.10 million -20.4%2.6%1.9 $28.35 8/13/2021979,000 shares $24.12 million -5.9%3.3%2 $24.64 7/30/20211,040,000 shares $24.99 million +11.2%3.5%2.2 $24.03 7/15/2021935,300 shares $22.58 million +11.1%3.2%2 $24.14 6/30/2021841,900 shares $21.59 million -49.9%2.9%1.8 $25.65 6/15/20211,680,000 shares $44.35 million -5.1%5.7%3.9 $26.40 5/28/20211,770,000 shares $36.36 million -8.3%6.0%5.9 $20.54 5/14/20211,930,000 shares $43.15 million +11.6%6.5%7.2 $22.36 4/30/20211,730,000 shares $41.36 million +11.6%5.9%7.1 $23.91 4/15/20211,550,000 shares $37.18 million +17.4%5.3%5.2 $23.99 3/31/20211,320,000 shares $42.73 million +128.4%4.5%4.7 $32.37 3/15/2021578,000 shares $22.62 million +24.4%2.0%2.1 $39.14 2/26/2021464,700 shares $19.42 million -5.9%1.6%2.1 $41.79 2/12/2021493,600 shares $17.92 million -13.8%1.7%2.4 $36.31 1/29/2021572,300 shares $18.40 million +0.4%1.9%2.9 $32.15 1/15/2021569,800 shares $18.93 million No Change1.9%3.5 $33.22 ITOS Short Interest - Frequently Asked Questions What is iTeos Therapeutics' current short interest? Short interest is the volume of iTeos Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 2,160,000 shares of ITOS short. 7.82% of iTeos Therapeutics' shares are currently sold short. Learn More on iTeos Therapeutics' current short interest. What is a good short interest ratio for iTeos Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ITOS shares currently have a short interest ratio of 5.0. Learn More on iTeos Therapeutics's short interest ratio. What is a good short interest percentage for iTeos Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.82% of iTeos Therapeutics' floating shares are currently sold short. Is iTeos Therapeutics' short interest increasing or decreasing? iTeos Therapeutics saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 2,160,000 shares, an increase of 4.3% from the previous total of 2,070,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is iTeos Therapeutics' float size? iTeos Therapeutics currently has issued a total of 36,120,000 shares. Some of iTeos Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. iTeos Therapeutics currently has a public float of 27,620,000 shares. How does iTeos Therapeutics' short interest compare to its competitors? 7.82% of iTeos Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to iTeos Therapeutics: Cabaletta Bio, Inc. (18.85%), HilleVax, Inc. (2.98%), Valneva SE (0.10%), Exscientia plc (3.66%), REGENXBIO Inc. (8.14%), Taysha Gene Therapies, Inc. (9.11%), Alector, Inc. (10.33%), Adaptive Biotechnologies Co. (8.92%), CARGO Therapeutics, Inc. (13.82%), Lexeo Therapeutics, Inc. (4.46%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short iTeos Therapeutics stock? Short selling ITOS is an investing strategy that aims to generate trading profit from iTeos Therapeutics as its price is falling. ITOS shares are trading down $0.60 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against iTeos Therapeutics? A short squeeze for iTeos Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ITOS, which in turn drives the price of the stock up even further. How often is iTeos Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ITOS, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Vaxart Short Interest Data Vericel Short Interest Data Immunocore Short Interest Data ADMA Biologics Short Interest Data Novavax Short Interest Data Recursion Pharmaceuticals Short Interest Data Kymera Therapeutics Short Interest Data Beam Therapeutics Short Interest Data Fusion Pharmaceuticals Short Interest Data Inhibrx Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ITOS) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeWARNING about the death of the U.S. dollar…Colonial MetalsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iTeos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.